Spots Global Cancer Trial Database for xmab2513
Every month we try and update this database with for xmab2513 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma | NCT00606645 | Hodgkin Lymphom... Anaplastic Larg... | XmAb2513 | 18 Years - | Xencor, Inc. |